SCHEMBL5790337

SCHEMBL5790337

C=CCNCCCc1cccc(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.46
SIGMAR1 Q99720 2/20 0.42
ADRB2 P07550 2/20 0.42
ADRB1 P08588 2/20 0.42
CNR1 P21554 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KCNH2 Q12809 1/20 0.40
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16641037 0.83 BCHE (0.44) SIGMAR1NPC1RAB9AKCNH2KDM4E
SCHEMBL18235905 0.80 SLC6A2 (0.45) TAAR1LMNAHPGDKDM4EALDH1A1
SCHEMBL2571087 0.80 DRD2 (0.50) TAAR1SIGMAR1CNR1LMNAKCNH2
SCHEMBL3234147 0.80 SIGMAR1 (0.67) SIGMAR1KCNH2
SCHEMBL5848061 0.78 TAAR1 (0.53) TAAR1HDAC1HRH3FDPS
SCHEMBL30462203 0.78 TAAR1 (0.53) TAAR1HDAC1HRH3FDPS
SCHEMBL8973390 0.77 FDFT1 (0.50) SIGMAR1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL8092500 0.75 TAAR1 (0.68) TAAR1HRH3FDPS
SCHEMBL8099771 0.75 TAAR1 (0.68) TAAR1HDAC3HDAC1HDAC2HDAC10
SCHEMBL18773839 0.75 TAAR1 (0.46) TAAR1SIGMAR1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663201-A1 A USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Korea Research Institute of Bioscience and Biotechnology (KR) 2006-06-07 EP disclosed
WO-2005004861-A1 A USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2005-01-20 WO disclosed